Noble Metal Complexes in Cancer Therapy: Unlocking Redox Potential for Next-Gen Treatments
Authors:
Open Access
- 19 February 2025
- journal article
- review article
- Published by MDPI AG in Inorganics
- Vol. 13 (2) , 64
Abstract
(1) Context: Cancer is still a major problem worldwide, and traditional therapies like radiation and chemotherapy often fail to alleviate symptoms because of side effects, systemic toxicity, and mechanisms of resistance. Beneficial anticancer effects that spare healthy tissues are made possible by the distinctive redox characteristics of noble metal complexes, especially those containing palladium, gold, silver, and platinum. (2) Methods: The redox processes, molecular targets, and therapeutic uses of noble metal complexes in cancer have been the subject of much study over the last 20 years; novel approaches to ligand design, functionalization of nanoparticles, and tumor-specific drug delivery systems are highlighted. (3) Results: Recent developments include Pt(IV) prodrugs and terpyridine-modified Pt complexes for enhanced selectivity and decreased toxicity; platinum complexes, like cisplatin, trigger reactive oxygen species (ROS) production and DNA damage. Functionalized gold nanoparticles (AuNPs) improve targeted delivery and theranostic capabilities, while gold complexes, particularly Au(I) and Au(III), inhibit redox-sensitive processes such as thioredoxin reductase (TrxR). (4) Conclusions: Ag(I)-based compounds and nanoparticles (AgNPs) induce DNA damage and mitochondrial dysfunction by taking advantage of oxidative stress. As redox-based anticancer medicines, noble metal complexes have the ability to transform by taking advantage of certain biochemical features to treat cancer more effectively and selectively.Keywords
This publication has 99 references indexed in Scilit:
- Stable Cyclometallated Palladium Complexes of Arylamides: Synthesis, Redox and Anticancer ActivitiesEuropean Journal of Inorganic Chemistry, 2024
- Unveiling the Potential of Innovative Gold(I) and Silver(I) Selenourea Complexes as Anticancer Agents Targeting TrxR and Cellular Redox HomeostasisChemistry – A European Journal, 2022
- Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectivenessMedicinal Research Reviews, 2021
- Studies towards Pyridine‐Based N,N,O‐Gold(III) Complexes: Synthesis, Characterization and ApplicationEuropean Journal of Organic Chemistry, 2020
- Silver Nanocarriers Targeted with a CendR Peptide Potentiate the Cytotoxic Activity of an Anticancer DrugAdvanced Therapeutics, 2020
- Metal‐Terpyridine Complexes in Catalytic Application – A Spotlight on the Last DecadeChemCatChem, 2020
- A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological StudiesChemMedChem, 2018
- Anticancer platinum‐based complexes with non‐classical structuresApplied Organometallic Chemistry, 2018
- Novel Gold and Silver Carbene Complexes Exert Antitumor Effects Triggering the Reactive Oxygen Species Dependent Intrinsic Apoptotic PathwayChemMedChem, 2017
- Anticancer Profile of a Series of Gold(III) (2‐phenyl)pyridine ComplexesChemMedChem, 2014